1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges,
Trends
4. Voice of Customer
5.
Global
Anti-Fungal Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Azoles, Echinocandins,
Polyenes, Allylamines, Others)
5.2.2. By Indication (Candidiasis, Aspergillosis,
Mucormycosis, Dermatophytosis, Others)
5.2.3. By Infection Type (Superficial Fungal
Infection, Systemic Fungal Infection)
5.2.4. By Route of Administration (Topical, Oral,
Parenteral, Others)
5.2.5. By End User (Homecare, Hospitals, Clinics,
Others)
5.2.6. By Distribution Channel (Retail Pharmacy,
Hospital Pharmacy, Online Pharmacy)
5.2.7. By Region
5.2.8. By Company (2022)
5.3. Market Map
6.
North
America Anti-Fungal Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1.
By Drug
Class
6.2.2.
By
Indication
6.2.3.
By Infection
Type
6.2.4. By Route Of Administration
6.2.5. By End User
6.2.6. By Distribution Channel
6.2.7.
By
Country
6.3. North America: Country Analysis
6.3.1. United States Anti-Fungal Drugs
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug
Class
6.3.1.2.2.
By Indication
6.3.1.2.3.
By
Infection Type
6.3.1.2.4.
By
Route Of Administration
6.3.1.2.5.
By End
User
6.3.1.2.6.
By
Distribution Channel
6.3.2. Canada Anti-Fungal Drugs Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug
Class
6.3.2.2.2.
By
Indication
6.3.2.2.3.
By
Infection Type
6.3.2.2.4.
By
Route Of Administration
6.3.2.2.5.
By End
User
6.3.2.2.6.
By
Distribution Channel
6.3.3. Mexico Anti-Fungal Drugs Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug
Class
6.3.3.2.2.
By
Indication
6.3.3.2.3.
By
Infection Type
6.3.3.2.4.
By
Route Of Administration
6.3.3.2.5.
By End
User
6.3.3.2.6.
By
Distribution Channel
7.
Europe
Anti-Fungal Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Indication
7.2.3. By Infection Type
7.2.4. By Route Of Administration
7.2.5. By End User
7.2.6. By Distribution Channel
7.2.7. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Anti-Fungal Drugs
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug
Class
7.3.1.2.2.
By
Indication
7.3.1.2.3.
By
Infection Type
7.3.1.2.4.
By
Route Of Administration
7.3.1.2.5.
By End
User
7.3.1.2.6.
By
Distribution Channel
7.3.2. United Kingdom Anti-Fungal Drugs
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug
Class
7.3.2.2.2.
By
Indication
7.3.2.2.3.
By
Infection Type
7.3.2.2.4.
By
Route Of Administration
7.3.2.2.5.
By End
User
7.3.2.2.6.
By
Distribution Channel
7.3.3. Italy Anti-Fungal Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By Drug
Class
7.3.3.2.2.
By
Indication
7.3.3.2.3.
By
Infection Type
7.3.3.2.4.
By
Route Of Administration
7.3.3.2.5.
By End
User
7.3.3.2.6.
By
Distribution Channel
7.3.4. France Anti-Fungal Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug
Class
7.3.4.2.2.
By
Indication
7.3.4.2.3.
By
Infection Type
7.3.4.2.4.
By
Route Of Administration
7.3.4.2.5.
By End
User
7.3.4.2.6.
By
Distribution Channel
7.3.5. Spain Anti-Fungal Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug
Class
7.3.5.2.2.
By
Indication
7.3.5.2.3.
By
Infection Type
7.3.5.2.4.
By
Route Of Administration
7.3.5.2.5.
By End
User
7.3.5.2.6.
By
Distribution Channel
8.
Asia-Pacific
Anti-Fungal Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Indication
8.2.3. By Infection Type
8.2.4. By Route Of Administration
8.2.5. By End User
8.2.6. By Distribution Channel
8.2.7. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Anti-Fungal Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug
Class
8.3.1.2.2.
By
Indication
8.3.1.2.3.
By
Infection Type
8.3.1.2.4.
By
Route Of Administration
8.3.1.2.5.
By End
User
8.3.1.2.6.
By Distribution
Channel
8.3.2. India Anti-Fungal Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug
Class
8.3.2.2.2.
By
Indication
8.3.2.2.3.
By
Infection Type
8.3.2.2.4.
By
Route Of Administration
8.3.2.2.5.
By End
User
8.3.2.2.6.
By
Distribution Channel
8.3.3. Japan Anti-Fungal Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug
Class
8.3.3.2.2.
By
Indication
8.3.3.2.3.
By
Infection Type
8.3.3.2.4.
By
Route Of Administration
8.3.3.2.5.
By End
User
8.3.3.2.6.
By
Distribution Channel
8.3.4. South Korea Anti-Fungal Drugs
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug
Class
8.3.4.2.2.
By
Indication
8.3.4.2.3.
By
Infection Type
8.3.4.2.4.
By
Route Of Administration
8.3.4.2.5.
By End
User
8.3.4.2.6.
By
Distribution Channel
8.3.5. Australia Anti-Fungal Drugs
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug
Class
8.3.5.2.2.
By
Indication
8.3.5.2.3.
By
Infection Type
8.3.5.2.4.
By
Route Of Administration
8.3.5.2.5.
By End
User
8.3.5.2.6.
By
Distribution Channel
9.
South
America Anti-Fungal Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Indication
9.2.3. By Infection Type
9.2.4. By Route Of Administration
9.2.5. By End User
9.2.6. By Distribution Channel
9.2.7. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Anti-Fungal Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug
Class
9.3.1.2.2.
By Indication
9.3.1.2.3.
By
Infection Type
9.3.1.2.4.
By
Route Of Administration
9.3.1.2.5.
By End
User
9.3.1.2.6.
By
Distribution Channel
9.3.2. Argentina Anti-Fungal Drugs
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug
Class
9.3.2.2.2.
By
Indication
9.3.2.2.3.
By
Infection Type
9.3.2.2.4.
By
Route Of Administration
9.3.2.2.5.
By End
User
9.3.2.2.6.
By
Distribution Channel
9.3.3. Colombia Anti-Fungal Drugs
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug
Class
9.3.3.2.2.
By
Indication
9.3.3.2.3.
By
Infection Type
9.3.3.2.4.
By
Route Of Administration
9.3.3.2.5.
By End
User
9.3.3.2.6.
By Distribution
Channel
10. Middle East and Africa Anti-Fungal Drugs
Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Indication
10.2.3. By Infection Type
10.2.4. By Route Of Administration
10.2.5. By End User
10.2.6. By Distribution Channel
10.2.7. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Anti-Fungal Drugs
Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Drug
Class
10.3.1.2.2.
By
Indication
10.3.1.2.3.
By
Infection Type
10.3.1.2.4.
By
Route Of Administration
10.3.1.2.5.
By End
User
10.3.1.2.6.
By
Distribution Channel
10.3.2. Saudi Arabia Anti-Fungal Drugs
Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Drug
Class
10.3.2.2.2.
By
Indication
10.3.2.2.3.
By
Infection Type
10.3.2.2.4.
By
Route Of Administration
10.3.2.2.5.
By End
User
10.3.2.2.6.
By
Distribution Channel
10.3.3. UAE Anti-Fungal Drugs Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Drug
Class
10.3.3.2.2.
By
Indication
10.3.3.2.3.
By
Infection Type
10.3.3.2.4.
By
Route Of Administration
10.3.3.2.5.
By End
User
10.3.3.2.6.
By
Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Anti-Fungal Drugs Market: SWOT
Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
15.5.1.
Abbott Laboratories Inc.
15.5.2.
Astellas Pharma Inc.
15.5.3.
Bayer AG
15.5.4.
GSK plc
15.5.5.
Glenmark Pharmaceuticals Limited
15.5.6.
Merck & Co. Inc.
15.5.7.
Novartis AG
15.5.8.
Pfizer Inc.
15.5.9.
Mycovia Pharmaceuticals, Inc.
15.5.10.
Apex Laboratories Pvt. Ltd.
16. Strategic Recommendations
17. About Us &
Disclaime